Nolato AB (publ) (NLTBF)
OTCMKTS · Delayed Price · Currency is USD
6.48
0.00 (0.00%)
Aug 6, 2025, 8:00 PM EDT
Nolato AB Market Cap
Nolato AB has a market cap or net worth of $1.62 billion as of August 8, 2025. Its market cap has increased by 12.03% in one year.
Market Cap
1.62B
Enterprise Value
1.75B
Revenue
1.01B
Ranking
n/a
PE Ratio
20.86
Stock Price
$6.48
Market Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 96.98M to 1.62B, an increase of 1,569.19%. That is a compound annual growth rate of 10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 1.62B | 22.46% |
| Dec 30, 2024 | 1.32B | -6.44% |
| Dec 29, 2023 | 1.41B | 0.05% |
| Dec 30, 2022 | 1.41B | -56.05% |
| Dec 30, 2021 | 3.21B | 18.34% |
| Dec 30, 2020 | 2.72B | 73.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |